Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MEDIFAST INC Common Stock (NY:MED)

13.93 +0.26 (+1.90%)
Streaming Delayed Price Updated: 1:55 PM EDT, Oct 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MEDIFAST INC Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
3 Reasons MED is Risky and 1 Stock to Buy Instead
Medifast has been treading water for the past six months, recording a small loss of 0.7% while holding steady at $13.57. The stock also fell short of the S&P 500’s 18.4% gain during that period. 
Via StockStory
Topics Stocks
3 Reasons to Avoid MED and 1 Stock to Buy Instead
Medifast currently trades at $13.57 per share and has shown little upside over the past six months, posting a small loss of 0.7%. The stock also fell short of the S&P 500’s 18.4% gain during that... 
Via StockStory
Topics Stocks
Evidence Links 5 & 1 Plan® to Improved Metabolic Health Outcomes
From Medifast
Via Business Wire
Earnings Scheduled For August 4, 2025
 
Via Benzinga
Is Medifast Gaining or Losing Market Support?
 
Via Benzinga
3 Cash-Heavy Stocks We Find Risky
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow. 
Via StockStory
Why Medifast (MED) Stock Is Trading Up Today
Shares of wellness company Medifast (NYSE:MED) jumped 4.5% in the afternoon session after the broader market rallied as Federal Reserve Chair Jerome Powell indicated a willingness to consider interest... 
Via StockStory
Topics Economy Stocks
Q2 Earnings Roundup: Medifast (NYSE:MED) And The Rest Of The Personal Care Segment
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the personal care industry, including Medifast (NYSE:MED) and its peers. 
Via StockStory
Topics Economy
2 Safe-and-Steady Stocks for Long-Term Investors and 1 We Brush Off
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
Dole, B&G Foods, Medifast, USANA, and MGP Ingredients Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally as a surprisingly subdued inflation report fueled hopes for an imminent interest rate cut from the U.S. Federal... 
Via StockStory
Topics Economy
MED Q2 Deep Dive: Ongoing Coach Decline and GLP-1 Integration Shape Outlook
Wellness company Medifast (NYSE:MED) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, but sales fell by 37.4% year on year to $105.6 million. On the other hand, next quarter’s revenue... 
Via StockStory
Medifast (MED) Stock Trades Up, Here Is Why
Shares of wellness company Medifast (NYSE:MED) jumped 3.9% in the afternoon session after the release of a favorable Consumer Price Index (CPI) report, which showed inflation cooling more than... 
Via StockStory
Topics Earnings Economy
Why Medifast (MED) Stock Is Up Today
Shares of wellness company Medifast (NYSE:MED) jumped 4.1% in the morning session after the company reported second-quarter financial results that surpassed analyst expectations. The company's revenue... 
Via StockStory
Topics Artificial Intelligence Earnings Economy
Medifast (MED) Q2 Revenue Falls 37%
Via The Motley Fool
Medifast (NYSE:MED) Exceeds Q2 Expectations But Quarterly Revenue Guidance Misses Expectations
Wellness company Medifast (NYSE:MED) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, but sales fell by 37.4% year on year to $105.6 million. On the other hand, next quarter’s revenue... 
Via StockStory
Medifast Announces Second Quarter 2025 Financial Results
From Medifast
Via Business Wire
Medifast (MED) Reports Q2: Everything You Need To Know Ahead Of Earnings
Wellness company Medifast (NYSE:MED) will be reporting earnings this Monday afternoon. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence World Trade
3 Unpopular Stocks We Keep Off Our Radar
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can... 
Via StockStory
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2025
From Medifast
Via Business Wire
1 Consumer Stock on Our Watchlist and 2 We Question
Consumer staples are considered safe havens in turbulent markets due to their inelastic demand profiles. But they’re also double-edged swords as they often lag in booming conditions, and this pattern... 
Via StockStory
Topics Stocks
1 Unprofitable Stock on Our Buy List and 2 to Approach with Caution
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. 
Via StockStory
2 Cash-Heavy Stocks to Keep an Eye On and 1 to Ignore
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits,... 
Via StockStory
Monday.com, Oxford Industries, and Medifast Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +1.5%, S&P 500 +1.0%) as reports pointed to easing tensions between Israel and Iran. The Wall Street Journal... 
Via StockStory
Topics Economy Initial Public Offering Stocks
1 Safe-and-Steady Stock on Our Watchlist and 2 to Question
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
Personal Care Stocks Q1 In Review: Medifast (NYSE:MED) Vs Peers
Let’s dig into the relative performance of Medifast (NYSE:MED) and its peers as we unravel the now-completed Q1 personal care earnings season. 
Via StockStory
Topics Economy
1 Stock Under $50 Worth Your Attention and 2 to Avoid
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
MED Q1 Earnings Call: Revenue Misses, Coach Productivity and GLP-1 Strategy in Focus
Wellness company Medifast (NYSE:MED) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 33.8% year on year to $115.7 million. Next quarter’s revenue guidance of $95 million... 
Via StockStory
1 Cash-Producing Stock with Impressive Fundamentals and 2 to Think Twice About
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
Herbalife (HLF) Q1 Earnings: What To Expect
Health and wellness products company Herbalife (NYSE:HLF) will be announcing earnings results tomorrow afternoon. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
Medifast (NYSE:MED) Misses Q1 Sales Targets
Wellness company Medifast (NYSE:MED) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 33.8% year on year to $115.7 million. Next quarter’s revenue guidance of $95 million... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.